Clinical Efficacy of Conventional Heparin Anticoagulation Combined with Apixaban in the Treatment of Patients with Cerebral Venous Thrombosis and Its Effect on Serum D-Dimer and FIB Expression

Table 4

Logistic analysis of curative effect.

		Univariate		Multivariate
			OR (95% CI)		OR (95% CI)
Gender	Male vs. female	0.561	1.358 (0.484-3.683)
Age	<40 vs. ≥40 years	0.031	2.167 (1.072-4.381)	0.048	1.654 (1.014-2.716)
Hospitalization time (d)	Unclassified	0.124	2.023 (0.825-4.960)
Time of diagnosis (d)	Unclassified	0.001	3.266 (1.644-6.475)	0.004	3.017 (1.426-6.316)
Hospitalization time (d)	Unclassified	0.039	1.036 (1.576-5.887)	0.382	1.688 (0.521-5.552)
Deep vein thrombosis	Yes vs. no	0.013	1.842 (1.152-2.977)	0.035	2.763 (1.093-5.388)
GCS score	>8 vs. ≤8	0.025	1.536 (0.284-1.987)	0.038	1.155 (0.653-2.118)
Infection	Yes vs. no	0.001	9.379 (6.482-13.166)	0.018	5.477 (1.247-23.318)
Drinking	Yes vs. no	0.034	2.158 (1.063-4.372)	0.739	1.227 (0.393-3.897)
Smoking	Yes vs. no	0.031	2.601 (1.068-6.269)	0.381	1.688 (0.531-5.552)
Complications	Yes vs. no	0.046	1.287 (0.739-2.286)	0.085	0.977 (0.188-1.964)
Treatment methods	Standard vs. apixaban	0.004	3.017 (1.426-6.318)	0.023	2.979 (1.185-7.648)
D-dimer	Unclassified	0.001	1.006 (1.664-5.411)	0.006	1.984 (1.232-3.264)
FIB	Unclassified	0.025	1.545 (0.284-1.979)	0.036	0.878 (0.394-1.194)

GCS: Glasgow Coma Scale; FIB: fibrinogen.